A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation
Clinical trial NCT04102098 · COMPLETED
Trial details
- NCT number
- NCT04102098
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2022-10-21
- Enrollment
- 668
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.